A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma

Agnihotri, 2016, Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions, Neuro. Oncol., 18, 160, 10.1093/neuonc/nov125 Ai, 2016, Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism, Cancer Lett., 373, 36, 10.1016/j.canlet.2016.01.009 Altenberg, 2004, Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes, Genomics, 84, 1014, 10.1016/j.ygeno.2004.08.010 Babic, 2013, EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer, Cell Metab., 17, 1000, 10.1016/j.cmet.2013.04.013 Bowman, 2017, GlioVis data portal for visualization and analysis of brain tumor expression datasets, Neuro. Oncol., 19, 139, 10.1093/neuonc/now247 Brennan, 2013, The somatic genomic landscape of glioblastoma, Cell, 155, 462, 10.1016/j.cell.2013.09.034 Brindle, 2008, New approaches for imaging tumour responses to treatment, Nat. Rev. Cancer, 8, 94, 10.1038/nrc2289 Byun, 2014, Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential (1)(8)F-FDG PET/CT and MRI, Eur. J. Nucl. Med. Mol. Imaging, 41, 1553, 10.1007/s00259-014-2746-2 Capello, 2016, Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest, Oncotarget, 7, 5598, 10.18632/oncotarget.6798 Chae, 2016, Mitochondrial Akt regulation of hypoxic tumor reprogramming, Cancer Cell, 30, 257, 10.1016/j.ccell.2016.07.004 Chaneton, 2012, Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer, Trends biochem. Sci., 37, 309, 10.1016/j.tibs.2012.04.003 Chiche, 2015, GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-kappaB-dependent induction of HIF-1alpha, Leukemia, 29, 1163, 10.1038/leu.2014.324 Clark, 2016, Molecular pathways: isocitrate dehydrogenase mutations in cancer, Clin. Cancer Res., 22, 1837, 10.1158/1078-0432.CCR-13-1333 Dang, 2010, Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, 465, 966, 10.1038/nature09132 Dawson, 1964, Lactic dehydrogenases: functions of the two types rates of synthesis of the two major forms can be correlated with metabolic differentiation, Science, 143, 929, 10.1126/science.143.3609.929 DeBerardinis, 2007, Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis, Proc. Natl. Acad. Sci. U. S. A., 104, 19345, 10.1073/pnas.0709747104 Deberardinis, 2008, Brick by brick: metabolism and tumor cell growth, Curr. Opin. Genet. Dev., 18, 54, 10.1016/j.gde.2008.02.003 Doherty, 2013, Targeting lactate metabolism for cancer therapeutics, J. Clin. Invest., 123, 3685, 10.1172/JCI69741 Elstrom, 2004, Akt stimulates aerobic glycolysis in cancer cells, Cancer Res., 64, 3892, 10.1158/0008-5472.CAN-03-2904 Erickson, 2010, Glutaminase: a hot spot for regulation of cancer cell metabolism?, Oncotarget, 1, 734, 10.18632/oncotarget.208 Federzoni, 2012, PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells, Blood, 119, 4963, 10.1182/blood-2011-09-378117 Fu, 2015, Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway, J. Hematol. Oncol., 8, 22, 10.1186/s13045-015-0117-5 Gravendeel, 2009, Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology, Cancer Res., 69, 9065, 10.1158/0008-5472.CAN-09-2307 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Harami-Papp, 2016, TP53 mutation hits energy metabolism and increases glycolysis in breast cancer, Oncotarget, 7, 67183, 10.18632/oncotarget.11594 He, 2016, Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer, Onco. Targets Ther., 9, 6099, 10.2147/OTT.S110203 Hegi, 2005, MGMT gene silencing and benefit from temozolomide in glioblastoma, N. Engl. J. Med., 352, 997, 10.1056/NEJMoa043331 Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809 Hu, 2014, Glycolytic genes in cancer cells are more than glucose metabolic regulators, J. Mol. Med. (Berl.), 92, 837, 10.1007/s00109-014-1174-x Jiang, 2014, PKM2 regulates chromosome segregation and mitosis progression of tumor cells, Mol. Cell, 53, 75, 10.1016/j.molcel.2013.11.001 Joseph, 1996, Enolase activity and isoenzyme distribution in human brain regions and tumors, J. Neurochem., 66, 2484, 10.1046/j.1471-4159.1996.66062484.x Koukourakis, 2005, Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer, Clin. Exp. Metastasis, 22, 25, 10.1007/s10585-005-2343-7 Koukourakis, 2009, Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy, Oncology, 77, 285, 10.1159/000259260 Louis, 2016 Louis, 2016, The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathol., 131, 803, 10.1007/s00401-016-1545-1 Mao, 2013, Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3, Proc. Natl. Acad. Sci. U. S. A., 110, 8644, 10.1073/pnas.1221478110 Muller, 2012, Passenger deletions generate therapeutic vulnerabilities in cancer, Nature, 488, 337, 10.1038/nature11331 Nabors, 2015, Central nervous system cancers, version 1.2015, J. Natl. Compr. Canc. Netw., 13, 1191, 10.6004/jnccn.2015.0148 Nguyen, 2016, PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis, J. Clin. Invest., 126, 681, 10.1172/JCI83587 Noushmehr, 2010, Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma, Cancer Cell, 17, 510, 10.1016/j.ccr.2010.03.017 Ostrom, 2015, CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012, Neuro. Oncol., 17, iv1, 10.1093/neuonc/nov189 Oudard, 1996, High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss, Br. J. Cancer, 74, 839, 10.1038/bjc.1996.446 Parker, 2015, Metabolic consequences of oncogenic IDH mutations, Pharmacol. Ther., 152, 54, 10.1016/j.pharmthera.2015.05.003 Parsons, 2008, An integrated genomic analysis of human glioblastoma multiforme, Science, 321, 1807, 10.1126/science.1164382 Patra, 2013, Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer, Cancer Cell, 24, 213, 10.1016/j.ccr.2013.06.014 Puzone, 2013, Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients, Mol. Cancer, 12, 97, 10.1186/1476-4598-12-97 Rickman, 2001, Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis, Cancer Res., 61, 6885 Roy, 2013, A genome-wide screen indicates correlation between differentiation and expression of metabolism related genes, PLoS One, 8, e63670, 10.1371/journal.pone.0063670 Sandulache, 2012, Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation, Mol. Cancer Ther., 11, 1373, 10.1158/1535-7163.MCT-12-0041 Sellick, 2008, Galactose metabolism in yeast-structure and regulation of the leloir pathway enzymes and the genes encoding them, Int. Rev. Cell Mol. Biol., 269, 111, 10.1016/S1937-6448(08)01003-4 Shime, 2008, Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway, J. Immunol., 180, 7175, 10.4049/jimmunol.180.11.7175 Song, 2014, Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma, Mol. Cancer, 13, 65, 10.1186/1476-4598-13-65 Tao, 2015, Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma, Mol. Cancer, 14, 170, 10.1186/s12943-015-0437-7 Tateishi, 2016, Myc-driven glycolysis is a therapeutic target in glioblastoma, Clin. Cancer Res., 22, 4452, 10.1158/1078-0432.CCR-15-2274 Toyonaga, 2017, Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor, Eur. J. Nucl. Med. Mol. Imaging, 44, 611, 10.1007/s00259-016-3541-z Tran, 2014, Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry, Neuro. Oncol., 16, 414, 10.1093/neuonc/not198 Turcan, 2012, IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype, Nature, 483, 479, 10.1038/nature10866 Vegran, 2011, Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB/IL-8 pathway that drives tumor angiogenesis, Cancer Res., 71, 2550, 10.1158/0008-5472.CAN-10-2828 Verhaak, 2010, Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1, Cancer Cell, 17, 98, 10.1016/j.ccr.2009.12.020 Vlashi, 2011, Metabolic state of glioma stem cells and nontumorigenic cells, Proc. Natl. Acad. Sci. U. S. A., 108, 16062, 10.1073/pnas.1106704108 Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309 Ward, 2012, Metabolic reprogramming: a cancer hallmark even warburg did not anticipate, Cancer Cell, 21, 297, 10.1016/j.ccr.2012.02.014 Whitfield, 2006, Common markers of proliferation, Nat. Rev. Cancer, 6, 99, 10.1038/nrc1802 Wike-Hooley, 1984, The relevance of tumour pH to the treatment of malignant disease, Radiother. Oncol., 2, 343, 10.1016/S0167-8140(84)80077-8 Wolf, 2011, Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme, J. Exp. Med., 208, 313, 10.1084/jem.20101470 Xu, 2011, Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases, Cancer Cell, 19, 17, 10.1016/j.ccr.2010.12.014 Yan, 2009, IDH1 and IDH2 mutations in gliomas, N. Engl. J. Med., 360, 765, 10.1056/NEJMoa0808710 Yang, 2012, EGFR-induced and PKCepsilon monoubiquitylation-dependent NF-kappaB activation upregulates PKM2 expression and promotes tumorigenesis, Mol. Cell, 48, 771, 10.1016/j.molcel.2012.09.028 Yang, 2012, PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis, Cell, 150, 685, 10.1016/j.cell.2012.07.018 Yang, 2011, Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation, Nature, 480, 118, 10.1038/nature10598